Cargando…
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
BACKGROUND: Glioblastoma multiforme (GBM) is the most common and aggressive brain tumor with poor clinical outcome. Identification and development of new markers could be beneficial for the diagnosis and prognosis of GBM patients. Deregulation of microRNAs (miRNAs or miRs) is involved in GBM. Theref...
Autores principales: | Qiu, Shuwei, Lin, Sheng, Hu, Dan, Feng, Yimin, Tan, Yang, Peng, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551827/ https://www.ncbi.nlm.nih.gov/pubmed/23302469 http://dx.doi.org/10.1186/1479-5876-11-10 |
Ejemplares similares
-
miR-1, miR-10b, miR-155, and miR-191 are novel regulators of BDNF
por: Varendi, Kärt, et al.
Publicado: (2014) -
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2019) -
MiR-210 and miR-155 as potential diagnostic markers for pre-eclampsia pregnancies
por: Gan, Lu, et al.
Publicado: (2017) -
Expression of miR-210, miR-137, and miR-153 in Patients with Acute Cerebral Infarction
por: Tian, Hongtao, et al.
Publicado: (2021) -
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
por: Nemecz, Miruna, et al.
Publicado: (2023)